Skip to main content
. 2015 Jan 27;112(4):739–744. doi: 10.1038/bjc.2015.1

Table 2. Response of primary chemotherapy in the patients with evaluable diseases (n=114).

  HtrA2-negative expression (n=27) (%) HtrA2-positive expression (n=87) (%) P-value
Response
CR 11 (41) 62 (71) <0.01
PR 4 (15) 12 (14)  
SD 3 (11) 3 (3)  
PD
9 (33)
10 (12)
 
Response rate 56% 85%  

Abbreviations: CR=complete response; PD=progressive disease; PR=partial response; SD=stable disease.

Response rate (%)=CR+PR/all cases.